Assyro AI

Orange Book product · Brand (NDA)

ASTEPRO ALLERGY

AZELASTINE HYDROCHLORIDE

Brand (NDA)NDA 213872OTC BAYER HLTHCARE

At a glance

Jun 17, 2021

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jun 17, 2021

    5 yr 1 mo ago

  2. Today

  3. Patent 8071073 expires

    Listed drug product patent expiration.

    Jun 04, 2028

    in 2 yr

Pharmaceutical detail

Active ingredient

AZELASTINE HYDROCHLORIDE

Strength

0.2055MG/SPRAY

Dosage form

SPRAY, METERED

Route

NASAL

TE code

Not listed

Application

NDA 213872

Product number

001

Marketing status

OTC

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8071073Jun 04, 2028in 2 yr
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.